3-Nitro-6,7-dihydro-5H-cyclopenta[b]pyridine

Catalog No.: 
ACPVQT029
CAS No.: 
84531-36-2
Molecular Formula: 
C8H8N2O2
Molecular Weight: 
164.16
3-Nitro-6,7-dihydro-5H-cyclopenta[b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$108.00In stockInquiry
100mg95%$157.00In stockIn stock
250mg95%$302.00In stockIn stock
1g95%$830.00In stockIn stock
5g95%$1802.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Nitro-6,7-dihydro-5H-cyclopenta[b]pyridine
IUPAC Name3-nitro-6,7-dihydro-5H-cyclopenta[b]pyridine
MDL No.MFCD09800609
Molecular FormulaC8H8N2O2
Molecular Weight164.16
SMILESO=[N+](C1=CN=C2C(CCC2)=C1)[O-]
InChI KeyMOSHQQPJHRYIHH-UHFFFAOYSA-N
Synonym3-NITRO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE;3-nitro-5H,6H,7H-cyclopenta[b]pyridine;6,7-dihydro-3-nitro-5H-Cyclopenta[b]pyridine;5H-Cyclopenta[b]pyridine,6,7-dihydro-3-nitro-;3-NITRO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE ISO 9001:2015 REACH
CAS No.84531-36-2
PubChem CID11564522

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPVQT029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPVQT029 route product structure diagram
    ACPVQT02984531-36-2In Stock
Inquiry

2. ACPVQT029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPVQT029 route product structure diagram
    ACPVQT02984531-36-2In Stock
Inquiry

3. ACPVQT029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPVQT029 route product structure diagram
    ACPVQT02984531-36-2In Stock
Inquiry

Comments (0)